Diagnostic Dilemma| Volume 131, ISSUE 8, P918-921, August 2018

Chamber-Made: Mural Endocarditis

      The patient began to feel better 2 days into an intravenous course of antibiotics, but this was deceptive. A 25-year-old woman with a history of polysubstance abuse and recent tick exposure presented after 10 days of fever, myalgia, and shortness of breath without cough. She used intranasal cocaine 1 day before admission, and her last use of an intravenous substance occurred 6 months earlier. She had no recent travel history.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Frontera J.A.
        • Gradon J.D.
        Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis.
        Clin Infect Dis. 2000; 30: 374-379
        • Adel A.
        • Jones E.
        • Johns J.
        • Farouque O.
        • Calafiore P.
        Bacterial mural endocarditis. A case series.
        Heart Lung Circ. 2014; 23: e172-e179
        • Hussain S.T.
        • Shrestha N.K.
        • Witten J.
        • et al.
        Rarity of invasiveness in right-sided infective endocarditis.
        J Thorac Cardiovasc Surg. 2018; 155: 54-61
        • Habib G.
        • Lancellotti P.
        • Antunes M.J.
        • et al.
        2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM).
        Eur Heart J. 2015; 36: 3075-3128